share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4:持股變動聲明-董事 AFEYAN NOUBAR
美股sec公告 ·  07/12 19:02
Moomoo AI 已提取核心訊息
On July 10, 2024, Noubar Afeyan, associated with Moderna, Inc. [MRNA], executed a series of open market sales transactions of the company's common stock. Afeyan disposed of a total of 15,000 shares at prices ranging from $116.01 to $119.95, resulting in a total market value of approximately $1.76 million. Following these transactions, Afeyan directly holds 2,269,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering, Inc. amount to 4,632,149 shares, with the largest portion held by Flagship Ventures Fund IV, L.P. at 3,880,328 shares.
On July 10, 2024, Noubar Afeyan, associated with Moderna, Inc. [MRNA], executed a series of open market sales transactions of the company's common stock. Afeyan disposed of a total of 15,000 shares at prices ranging from $116.01 to $119.95, resulting in a total market value of approximately $1.76 million. Following these transactions, Afeyan directly holds 2,269,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering, Inc. amount to 4,632,149 shares, with the largest portion held by Flagship Ventures Fund IV, L.P. at 3,880,328 shares.
2024年7月10日,與moderna有關的Noubar Afeyan [MRNA]執行了一系列公司股票的公開市場銷售交易。Afeyan以116.01美元至119.95美元的價格拋售了總計15,000股,從而獲得了約176萬元的總市值。在進行這些交易後,Afeyan直接持有2,269,015股moderna的股份。此外,通過Flagship Pioneering,Inc.與各種實體的間接持股總數爲4,632,149股,其中由Flagship Ventures Fund IV,L.P.持有的股份最大,在3,880,328股。
2024年7月10日,與moderna有關的Noubar Afeyan [MRNA]執行了一系列公司股票的公開市場銷售交易。Afeyan以116.01美元至119.95美元的價格拋售了總計15,000股,從而獲得了約176萬元的總市值。在進行這些交易後,Afeyan直接持有2,269,015股moderna的股份。此外,通過Flagship Pioneering,Inc.與各種實體的間接持股總數爲4,632,149股,其中由Flagship Ventures Fund IV,L.P.持有的股份最大,在3,880,328股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息